Evidence map›Paper›PMID 32077093›Full record

ArticleBritish journal of pharmacology2020

Inhibition of fatty acid amide hydrolase in the CNS prevents and reverses morphine tolerance in male and female mice.

Yannick Fotio, Francesca Palese, Pablo Guaman Tipan, Faizy Ahmed, Daniele Piomelli

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Endocannabinoids and related lipids linked to social exclusion in individuals with chronic non-medical prescription opioid use.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Persistent Exposure to ΔThe Journal of pharmacology and experimental therapeutics · 2021
    Article
  8. Review
  9. Article
  10. Frontiers in synaptic neuroscience · 2021
    Article
  11. Article
  12. Positive Allosteric Modulation of CBFrontiers in molecular neuroscience · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yannick FotioDepartment of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, Irvine, California.
Francesca PaleseDepartment of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, Irvine, California.
Pablo Guaman TipanDepartment of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, Irvine, California.
Faizy AhmedDepartment of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, Irvine, California.
Daniele PiomelliDepartment of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, Irvine, California.
University of California, Irvine · US

Funding

Peripheral FAAH as a target for novel analgesicsR42DA033683 · NIDA · ANTEANA THERAPEUTICS, INC. · PI PIOMELLI, DANIELE · 2017 to 2019
$1.5M
NIDA NIH HHS R42 DA033683NIH HHS R41 DA041871-01
6 · The paper itself

Abstract

background and purposeFatty acid amide hydrolase (FAAH) is an intracellular serine amidase that terminates the signalling of various lipid messengers involved in pain regulation, including anandamide and palmitoylethanolamide. Here, we investigated the effects of pharmacological or genetic FAAH removal on tolerance to the anti-nociceptive effects of morphine. EXPERIMENTAL APPROACH: We induced tolerance in male and female mice by administering twice-daily morphine for 7 days while monitoring nociceptive thresholds by the tail immersion test. The globally active FAAH inhibitor URB597 (1 and 3 mg·kg KEY

resultsURB597 prevented and reversed morphine tolerance in both male and female mice. This effect was mimicked by genetic FAAH deletion, but not by URB937. Treatment with AM630 suppressed, whereas treatment with AM251 or GW6471, attenuated the effects of URB597. Anandamide mobilization was enhanced in the spinal cord of morphine-tolerant mice. mRNA levels of the anandamide-producing enzyme N-acyl-phosphatidylethanolamine PLD (NAPE-PLD) and the palmitoylethanolamide receptor PPAR-α, but not those for CB

Indexed as

AmidohydrolasesMorphineAnimalsEndocannabinoidsEnzyme InhibitorsFatty Acid Amide HydrolasesFemaleMaleMicePainReceptor, Cannabinoid, CB1Spinal CordAmidohydrolasesEndocannabinoidsEnzyme InhibitorsFatty Acid Amide HydrolasesMorphineReceptor, Cannabinoid, CB1

Identifiers

PMID32077093
PMCPMC7280000
OpenAlexW3008376098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.